Addition of nivolumab significantly enhanced ex vivo proliferative responses of CD4 + TIL and almost significantly enhanced CD8 + TIL proliferation to tumor antigens (Fig. 7 a‐c).
← all excerpts
GITR ligation enhances functionality of tumor-infiltrating T cells in hepatocellular carcinoma.
1
—
—